January 19th, 2023: Marina Sirota, Bakar Computational Health Sciences Institute, UCSF, “Leveraging Molecular and Clinical Data to Better Understand Alzheimer’s Disease”

Marina Sirota


December 15th, 2022: Sepideh Modrek, San Francisco State University, Health Equity Institute & David Rehkopf, Stanford University, “Long-term effects of Local Area New Deal Work-Relief in Childhood on Educational and Cognitive Outcomes over the Life Course”

Sepideh Modrek & David Rehkopf

December 1, 2022: Tara E. Jenson, Zilber School of Public Health, University of Wisconsin – Milwaukee, “Environmental Cadmium Exposures, Cognitive Performance in Older Adults, and Subsequent Alzheimer’s Disease Mortality.”

Tara Jenson

November 3, 2022: Tianhao Wang, Rush Alzheimer’s Disease Center, Rush University Medical Center, “The ‘cognitive clock’: A novel indicator of brain health”

Tianhao Wang

October 20, 2022: Emma Nichols, Johns Hopkins Bloomberg School of Public Health, The use of algorithms for the identification of incident dementia: challenges and potential biases:

Emma Nichols

October 6, 2022: John (Rob) Warren, Minnesota Population Center, University of Minnesota “High School & Beyond: Turning an Education Cohort Study into an ADRD Study.”

Rob Warren

September 15, 2022: Marcia P Jimenez, Boston University &  L. Paloma Rojas-Saunero, UCLA “Racial and ethnic differences in the risk of dementia under hypothetical blood-pressure-lowering interventions: The Multi-Ethnic Study of Atherosclerosis.”

Marcia P Jimenez &  L. Paloma Rojas-Saunero


November 18, 2021: Madhav Thambisetty, NIA/NIH, “From Mechanisms to Medicines: realizing the DREAM of an Alzheimer’s cure.”


October 28, 2021: Venexia Walker, University of Bristol, Predicting drug repurposing opportunities for Alzheimer’s disease prevention using genome-wide association study data.”


October 7, 2021: Maria Glymour, UCSF, “Introduction to using Directed Acyclic Graphs to represent assumptions, guide analysis decisions, and argue with colleagues.”


July 15, 2021: Thomas Nedelec, Paris Brain Institute, “Data-driven identification of health conditions associated with incident Alzheimer’s disease dementia risk: a 15 years follow-up cohort from electronic health records in France and the United Kingdom.”


April 29, 2021: “Re-orienting to MELODEM”

Re-orienting to MELODEM

April 1, 2021: Zach Baucom, Boston University School of Public Health, “Using State Space Models for Longitudinal Neuropsychological Outcomes”

Zach Baucom

March 18, 2021: Lon Schneider, University of Southern California, “Methodological features & FDA’s regulatory guidance on aducanumab and Alzheimer drug development”

Lon Schneider

March 4, 2021: Terry Therneau, Mayo Clinic, “Multi-state survival models and dementia”

Terry Therneau

February 18, 2021: Andrew Stokes, Assistant Professor of Global Health, Boston University School of Public Health, “Estimations of the Association of Dementia with US Mortality Levels Using Linked Survey and Mortality Records”

Andrew Stokes

February 11, 2021: Julie Zissimopoulos, Price School of Public Policy and Schaeffer Center for Health Policy and Economics, University of Southern California, “Drug therapies for chronic conditions and risk of ADRD:  analyses using claims data”

Julie Zissimpoulos

February 4, 2021: Justina Avila-Rieger, Taub Institute for Research on Alzheimer’s Disease and the Aging Brain, Columbia University Irving Medical Center, “Using Multilevel Analysis of Individual Heterogeneity & Discriminatory Accuracy (MAIHDA) to Examine Intersectional Inequalities in Cognitive Aging”

Justina Avila-Rieger


December 10, 2020: Maria Corrada, University of California, Irvine, & Sevil Yasar, Johns Hopkins University, “Statin Use, Hx of High Cholesterol & Risk of Dementia in the Oldest-old: illustration of challenges when analyzing pharmacoepidemiological data”

Maria Corrada & Sevil Yasar

December 3, 2020: Eric Tchetgen Tchetgen, Luddy Family President’s Distinguished Professor and Professor of Statistics, Department of Statistics, The Wharton School, The University of Pennsylvania, “MR GENIUS: A Principled Approach to Robust Mendelian Randomization Interference”

Eric Tchetgen Tchetgen

July 9, 2020: Bryan James, Rush Alzheimer’s Disease Center, Rush University Medical Center“Implications of covid for dementia researchers”

Bryan James